Galera Therapeutics, Inc. Insider Trading
GRTX
No open-market buying or selling by insiders.
The last open-market buy by an executive or director was in Dec 2024.
Get an email when GRTX's executives or directors buy, or make a large sale outside a plan.
Trades · last 2 years
| Date | Insider | Trade | Shares | Price | Value | Of their stake | Filing |
|---|---|---|---|---|---|---|---|
| Nov 20, 2025 | Mel Sorensen President and CEO | SoldNo plan | 70,000 | $0.02 | 1K | 26% | Form 4 |
| Dec 30, 2024 | Nancy T Chang Director | Bought | 7,644,932 | $0.07 | 535K | New | Form 4 |
- Nov 20, 2025No planMel SorensenPresident and CEO · sold 70,000 at $0.021K26% of stake
- Dec 30, 2024Nancy T ChangDirector · bought 7,644,932 at $0.07535KNew position
Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.
Peers
Pharmaceutical Preparations · Pick stocks to compare with GRTX
Spot a number that looks wrong? Check it in GRTX's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing GRTX
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.